carvedilol has been researched along with Diabetes Mellitus, Type 1 in 2 studies
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Inflammation is one of the main mechanisms of pancreatic β-cell damage and the development of type 1 diabetes (T1D)." | 1.62 | Carvedilol prevents pancreatic β-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory cytokines, NF-κB, COX-2, iNOS and oxidative stress. ( Amirshahrokhi, K; Zohouri, A, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amirshahrokhi, K | 1 |
| Zohouri, A | 1 |
| Diogo, CV | 1 |
| Deus, CM | 1 |
| Lebiedzinska-Arciszewska, M | 1 |
| Wojtala, A | 1 |
| Wieckowski, MR | 1 |
| Oliveira, PJ | 1 |
2 other studies available for carvedilol and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Carvedilol prevents pancreatic β-cell damage and the development of type 1 diabetes in mice by the inhibition of proinflammatory cytokines, NF-κB, COX-2, iNOS and oxidative stress.
Topics: Animals; Blood Glucose; Body Weight; Carvedilol; Cyclooxygenase 2; Cytokines; Diabetes Mellitus, Typ | 2021 |
Carvedilol and antioxidant proteins in a type I diabetes animal model.
Topics: Adrenergic beta-Antagonists; Animals; Antioxidants; Blood Glucose; Carbazoles; Carvedilol; Caspase 3 | 2017 |